IIR Globe IIR Data IIR
social media icon social media icon social media icon social media icon social media icon social media icon social media icon social media icon

You are Trying to View a Premium Article

South Korea Gets Biopharma Boost with CMO Samsung BioLogics $740 Million Investment

pharmaceutical

Industry Segment: Pharmaceutical & Biotech | Word Count: 311 Words

SUGAR LAND, TEXAS--April 21, 2017--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--Samsung BioLogics (Incheon, South Korea) is busy raising South Korea's profile within the global biopharma industry. 100% of its products in the country are exported.

Within this article: Details on the progress of Samsung BioLogics' projects.


Login or Register for Instant Access

This Premium Article can be purchased individually or as part of a subscription

Subscribe Now! All Fields Required...

Subscription Type:

Pricing Help?

  • Pay-Per-Article - $5.85
  • Annual Subscription - $235.00
  • Annual Subscription with Archive - $395.00

All Members Receive the Following Free Resources:

  • North American Project & Gap Spending
  • Market Maps & Stats - Capital & Maintenance Activity
  • Current Economic Indicators
  • Free Daily Industrial Articles
  • Monthly Industrial Newsletter